Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase
20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 ω-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimu...
Saved in:
Published in | American journal of physiology. Renal physiology Vol. 284; no. 3; pp. F474 - F479 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
01.03.2003
|
Subjects | |
Online Access | Get full text |
ISSN | 1931-857X 1522-1466 |
DOI | 10.1152/ajprenal.00239.2002 |
Cover
Abstract | 20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 ω-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 ± 8.5 vs. 24.6 ± 5.3 ng · mg protein −1 · 30 min −1 , respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 μM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 ± 13.2 to 101.8 ± 42.6 ng · mg protein −1 · 30 min −1 ( P < 0.03), and interlobar arteries, from 31.7 ± 15.1 to 61.9 ± 29.4 ng · mg protein −1 · 30 min −1 ( P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone. |
---|---|
AbstractList | 20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 omega-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 +/- 8.5 vs. 24.6 +/- 5.3 ng. mg protein(-1). 30 min(-1), respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 microM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 +/- 13.2 to 101.8 +/- 42.6 ng. mg protein(-1). 30 min(-1) (P < 0.03), and interlobar arteries, from 31.7 +/- 15.1 to 61.9 +/- 29.4 ng. mg protein(-1). 30 min(-1) (P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone.20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 omega-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 +/- 8.5 vs. 24.6 +/- 5.3 ng. mg protein(-1). 30 min(-1), respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 microM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 +/- 13.2 to 101.8 +/- 42.6 ng. mg protein(-1). 30 min(-1) (P < 0.03), and interlobar arteries, from 31.7 +/- 15.1 to 61.9 +/- 29.4 ng. mg protein(-1). 30 min(-1) (P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone. 20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 ω-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 ± 8.5 vs. 24.6 ± 5.3 ng · mg protein −1 · 30 min −1 , respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 μM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 ± 13.2 to 101.8 ± 42.6 ng · mg protein −1 · 30 min −1 ( P < 0.03), and interlobar arteries, from 31.7 ± 15.1 to 61.9 ± 29.4 ng · mg protein −1 · 30 min −1 ( P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone. 20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 omega-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It is released from preglomerular microvessels by ANG II and is subject to metabolism by cyclooxygenase (COX). Because low-salt (LS) intake stimulates the renin-angiotensin system and induces renal cortical COX-2 expression, we examined 20-HETE release from renal arteries (interlobar and arcuate and interlobular arteries) obtained from 6- to 7-wk-old male Sprague-Dawley rats fed either normal salt (0.4% NaCl) or LS (0.05% NaCl) diets for 10 days. With normal salt intake, the levels of 20-HETE recovered were similar in arcuate and interlobular arteries and interlobar arteries: 30.1 +/- 8.5 vs. 24.6 +/- 5.3 ng. mg protein(-1). 30 min(-1), respectively. An LS diet increased 20-HETE levels in the incubate of either arcuate and interlobular or interlobar renal arteries only when COX was inhibited. Addition of indomethacin (10 microM) to the incubate of arteries obtained from rats fed an LS diet resulted in a two- to threefold increase in 20-HETE release from arcuate and interlobular arteries, from 39.1 +/- 13.2 to 101.8 +/- 42.6 ng. mg protein(-1). 30 min(-1) (P < 0.03), and interlobar arteries, from 31.7 +/- 15.1 to 61.9 +/- 29.4 ng. mg protein(-1). 30 min(-1) (P < 0.05) compared with release of 20-HETE when COX was not inhibited. An LS diet enhanced vascular expression of cytochrome P-4504A and COX-2 in arcuate and interlobular arteries; COX-1 was unaffected. Metabolism of 20-HETE by COX is proposed to represent an important regulatory mechanism in setting preglomerular microvascular tone. |
Author | McGiff, John C. Carroll, Mairead A. Cheng, Monica K. |
Author_xml | – sequence: 1 givenname: Monica K. surname: Cheng fullname: Cheng, Monica K. organization: Department of Pharmacology, New York Medical College, Valhalla, New York – sequence: 2 givenname: John C. surname: McGiff fullname: McGiff, John C. organization: Department of Pharmacology, New York Medical College, Valhalla, New York – sequence: 3 givenname: Mairead A. surname: Carroll fullname: Carroll, Mairead A. organization: Department of Pharmacology, New York Medical College, Valhalla, New York |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12419775$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kElPwzAQhS1URBf4BUgoJ24pXpIm5oYqNqkSEovEzbKdSXHlxsVOEfn3uBsHDpxmNPPe08w3RL3GNYDQOcFjQnJ6JRcrD420Y4wp42MayxEaxA1NSTaZ9GLPGUnLvHjvo2EIC4wxIZScoD6hGeFFkQ_Qy_MmIpG-BW9iQ3H60VXefXdgtAuyhdZLaJzRidSmSix8gQ3XiYf52srWuCZRXaI7bV30zGNYgFN0XEsb4GxfR-jt7vZ1-pDOnu4fpzezVDNO2jTHjJRQlUxRVutMYqVYzWmFM8mLuqCKZopzUCALWseLWVnncZRzolmVTTgboctd7sq7zzWEVixN0GCtbMCtgygoLzlhZRRe7IVrtYRKrLxZSt-JA4Yo4DuB9i4ED7XQpt1-F783VhAsNsjFAbnYIhcb5NHL_nh_4_9x_QD6PYgo |
CitedBy_id | crossref_primary_10_1038_sj_bjp_0705640 crossref_primary_10_1155_2015_149408 crossref_primary_10_1161_HYPERTENSIONAHA_107_105395 crossref_primary_10_3390_pharmaceutics9010009 crossref_primary_10_1007_s00424_013_1262_8 crossref_primary_10_1016_j_abb_2008_06_025 crossref_primary_10_1111_apha_13297 crossref_primary_10_1681_ASN_2014090868 crossref_primary_10_3390_biomedicines10020407 |
Cites_doi | 10.1016/0003-2697(76)90527-3 10.1152/ajprenal.00265.2001 10.1152/ajprenal.1990.258.4.F781 10.1042/bj2380283 10.1074/jbc.M003505200 10.1016/S0021-9258(19)36671-2 10.1152/ajprenal.1992.262.1.F8 10.1152/ajprenal.1999.277.3.F360 10.1152/ajprenal.1998.274.1.F148 10.1152/ajprenal.2000.279.3.F544 10.1152/ajprenal.1992.262.4.F591 10.1016/S0021-9258(18)80115-6 10.1016/S0002-9343(70)80073-0 10.1016/S0021-9258(18)98897-6 10.1152/ajprenal.1994.266.6.F934 10.1016/0006-291X(92)91686-K 10.1016/S0022-3565(25)23636-9 10.1016/S0022-3565(25)11191-9 10.1152/ajprenal.1994.266.2.F275 10.1016/S0895-7061(01)02034-9 10.1152/ajpregu.1996.270.1.R217 10.1152/ajpregu.1996.271.4.R863 10.1172/JCI119640 10.1152/ajprenal.1998.274.3.F433 10.1161/01.RES.40.6.590 10.1038/ki.1997.234 10.1152/ajprenal.1998.274.3.F481 10.1161/01.RES.72.1.126 |
ContentType | Journal Article |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1152/ajprenal.00239.2002 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1522-1466 |
EndPage | F479 |
ExternalDocumentID | 12419775 10_1152_ajprenal_00239_2002 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: HL-25394 – fundername: NHLBI NIH HHS grantid: HL-34300 |
GroupedDBID | --- 23M 2WC 39C 53G 5GY 5VS 6J9 AAFWJ AAYXX ACPRK ADBBV AENEX AFFNX ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW C1A CITATION E3Z EBS EJD EMOBN F5P GX1 H13 ITBOX KQ8 OK1 P2P PQQKQ RAP RHI RPL RPRKH TR2 W8F WOQ XSW YSK 4.4 8M5 BKKCC CGR CUY CVF DIK ECM EIF NPM RHF 7X8 |
ID | FETCH-LOGICAL-c391t-50318ed83b23fc4a0bb3f92d04a97f72b24b99ebea72f12438f524b591c3d4693 |
ISSN | 1931-857X |
IngestDate | Fri Jul 11 05:55:56 EDT 2025 Wed Feb 19 01:28:00 EST 2025 Sun Jul 06 05:05:49 EDT 2025 Thu Apr 24 23:08:17 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c391t-50318ed83b23fc4a0bb3f92d04a97f72b24b99ebea72f12438f524b591c3d4693 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 12419775 |
PQID | 72989138 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_72989138 pubmed_primary_12419775 crossref_citationtrail_10_1152_ajprenal_00239_2002 crossref_primary_10_1152_ajprenal_00239_2002 |
PublicationCentury | 2000 |
PublicationDate | 2003-03-01 2003-Mar 20030301 |
PublicationDateYYYYMMDD | 2003-03-01 |
PublicationDate_xml | – month: 03 year: 2003 text: 2003-03-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | American journal of physiology. Renal physiology |
PublicationTitleAlternate | Am J Physiol Renal Physiol |
PublicationYear | 2003 |
References | B20 B21 B22 B23 B24 B26 B27 B28 B29 Carroll MA (B6) 1992; 260 Schwartzman ML (B25) 1989; 264 Escalante B (B12) 1989; 248 Carroll MA (B7) 2001; 7 Capdevila JH (B2) 1992; 267 B30 B11 B13 B14 B15 B16 B17 B18 B19 B1 B3 B4 B5 B9 Carroll MA (B8) 1991; 266 |
References_xml | – ident: B1 doi: 10.1016/0003-2697(76)90527-3 – ident: B17 doi: 10.1152/ajprenal.00265.2001 – ident: B26 doi: 10.1152/ajprenal.1990.258.4.F781 – ident: B24 doi: 10.1042/bj2380283 – ident: B18 doi: 10.1074/jbc.M003505200 – volume: 267 start-page: 21720 year: 1992 ident: B2 publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)36671-2 – ident: B20 doi: 10.1152/ajprenal.1992.262.1.F8 – ident: B13 doi: 10.1152/ajprenal.1999.277.3.F360 – ident: B14 doi: 10.1152/ajprenal.1998.274.1.F148 – ident: B9 doi: 10.1152/ajprenal.2000.279.3.F544 – ident: B21 doi: 10.1152/ajprenal.1992.262.4.F591 – volume: 264 start-page: 11658 year: 1989 ident: B25 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)80115-6 – ident: B11 doi: 10.1016/S0002-9343(70)80073-0 – volume: 266 start-page: 12306 year: 1991 ident: B8 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)98897-6 – ident: B30 doi: 10.1152/ajprenal.1994.266.6.F934 – ident: B22 doi: 10.1016/0006-291X(92)91686-K – volume: 248 start-page: 229 year: 1989 ident: B12 publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)23636-9 – volume: 260 start-page: 104 year: 1992 ident: B6 publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)11191-9 – ident: B29 doi: 10.1152/ajprenal.1994.266.2.F275 – ident: B5 doi: 10.1016/S0895-7061(01)02034-9 – ident: B15 doi: 10.1152/ajpregu.1996.270.1.R217 – ident: B4 doi: 10.1152/ajpregu.1996.271.4.R863 – ident: B23 doi: 10.1172/JCI119640 – ident: B19 doi: 10.1152/ajprenal.1998.274.3.F433 – ident: B27 doi: 10.1161/01.RES.40.6.590 – ident: B3 doi: 10.1038/ki.1997.234 – ident: B28 doi: 10.1152/ajprenal.1998.274.3.F481 – ident: B16 doi: 10.1161/01.RES.72.1.126 – volume: 7 start-page: 567 year: 2001 ident: B7 publication-title: Med Sci Monit |
SSID | ssj0001121 |
Score | 1.8128124 |
Snippet | 20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 ω-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels. It... 20-HETE, a potent vasoconstrictor, is generated by cytochrome P-450 omega-hydroxylases and is the principal eicosanoid produced by preglomerular microvessels.... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | F474 |
SubjectTerms | Animals Blotting, Western Cyclooxygenase 1 Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Cyclooxygenase Inhibitors - pharmacology Cytochrome P-450 CYP4A Cytochrome P-450 Enzyme System - metabolism Hydroxyeicosatetraenoic Acids - analysis Hydroxyeicosatetraenoic Acids - metabolism In Vitro Techniques Indomethacin - pharmacology Isoenzymes - metabolism Kidney - blood supply Male Membrane Proteins Mixed Function Oxygenases - metabolism Prostaglandin-Endoperoxide Synthases - metabolism Rats Rats, Sprague-Dawley Renal Artery - chemistry Renal Artery - drug effects Renal Artery - metabolism Sodium, Dietary - pharmacology |
Title | Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase |
URI | https://www.ncbi.nlm.nih.gov/pubmed/12419775 https://www.proquest.com/docview/72989138 |
Volume | 284 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvE2xcytUPiJeRkdhOnPA2TSvTWMetlfoW-SpAXYK69KH8eo7tpOnExu0lqqw6jvydnJzL53MQesFFLBi3WUQ0txFjOotyKWgkpC0yrVyncs-2OMuOp-xkls4Gg5MN1tKykfvqx5XnSv4HVRgDXN0p2X9Adn1TGIDfgC9cAWG4_hXGn4yzJT0r0wW-wUX7stKOl2IA3wuwIpuFMFXtSrKqr3pv7ghCngK3CB3oHfRgfqqVmtcwC9bpcjVdXdoun7NRYMLHQnwwfn8vPEA_0pMFTNAhTmUo0cdSx-ptWwfSU3bWIdpDVwsyZEDGArSw0G2QtQtI0J6R1erQgiZRnvLZppIloRFcK010Q2WOWGjT86suT11tWPHN1fYEP8Qfw_Wckv7T1aXrz96Xo-npaTk5mk1uoJuEc5-yf_exrxwPdmUSGAbh4doKVLDI6yuWuGylXON6eBNkcgdtt74DPgiCcBcNTLWDdg8q0dTnK_wSf1jjsINujVvSxC767FHCnZjg68UEOzHBQUze4F5IsFzhy0JyD01HR5PD46jtpREpWiRNlDrlbXROJaFWMRFLSW1BdMxEwS0nkjBZFPBGC04s2Hw0tykMpUWiqGZZQe-jraquzEOEUy3ByckJN7llWoODITOZxLLIDY81tUNEur0rVVto3vU7mZfe4UxJ2W146TfcdUIlQ_RqPel7qLPy-78_70ApQR-6JJeoTL28KLlrKZDQfIgeBKz624GxCt5O-uiPcx-j271gP0FbzWJpnoLt2chnXqh-AnM8iZM |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Renal+arterial+20-hydroxyeicosatetraenoic+acid+levels%3A+regulation+by+cyclooxygenase&rft.jtitle=American+journal+of+physiology.+Renal+physiology&rft.au=Cheng%2C+Monica+K&rft.au=McGiff%2C+John+C&rft.au=Carroll%2C+Mairead+A&rft.date=2003-03-01&rft.issn=1931-857X&rft.volume=284&rft.issue=3&rft.spage=F474&rft_id=info:doi/10.1152%2Fajprenal.00239.2002&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-857X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-857X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-857X&client=summon |